All instruments
Alivus Life Sciences Limited
Formerly Glenmark Life Sciences Limited
- Stock
- ALIVUS
- NSE
- ₹1,309.50−2.41%
- Delayed close, 16 Oct
Details
- INE03Q201024
- Healthcare
- Pharmaceuticals
- Face value ₹2
- Market cap ₹16,077 Cr
Paid for 2 years without a break
Dividend per share by FY
Split-adjusted · FY27 to date · FY of the ex-date
| Financial year | Total dividend |
|---|---|
| FY22 | ₹10.50 |
| FY23 | ₹31.50 |
| FY24 | ₹22.50 |
| FY26 | ₹5.00 |
| FY27 | ₹5.00 |
TTM payout
₹5.00
1 payout in 12 months
Yield
0.38%
Dividend yield · trailing 12 months
52-wk closing range ₹860.05 – ₹1,443.70
Yield and payout totals recalculated 19 Oct 2026.
Recent payouts
· 6 on record since FY22| Ex-date | Type | Record date | Amount |
|---|---|---|---|
| 01 Sep 2026 | Final | same day | ₹5.00 |
| 01 Sep 2025 | Final | same day | ₹5.00 |
| 17 Oct 2023 | Interim | same day | ₹22.50 |
| 24 Mar 2023 | Interim | same day | ₹21.00 |
| 15 Sep 2022 | Final | — | ₹10.50 |
Income calculator
₹380
Expected income per year, before tax, at the current 0.38% yield
≈ 76 shares at ₹1,309.50, using ₹99,522 of the ₹1,00,000. Based on the last twelve months’ payouts — not a forecast, and dividends are taxed at your own slab rate.
Similar current yields
Same asset type, ordered by distance from this instrument’s published trailing-12-month yield. These are not business-sector peers or recommendations.